Epizyme, Inc. EPZM
1.47 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
1.47 Day range 1.50
52-week range unavailable
News
globenewswire.com Ipsen to acquire Epizyme, expanding its portfolio in oncology PARIS, FRANCE & CAMBRIDGE, MASSACHUSETTS, 27 June 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) and Epizyme (Nasdaq: EPZM) today announced that they have entered into a definitive merger agreement under…
globenewswire.com Ipsen extends expiration date of tender offer for Epizyme, Inc. to 11 August 2022 PARIS, FRANCE, 5 August 2022 – Ipsen S.A. (Euronext: IPN; ADR: IPSEY) today announced that Hibernia Merger Sub, Inc. (Purchaser), its wholly owned indirect subsidiary, has extended the expiration…
globenewswire.com Ipsen completes acquisition of Epizyme expanding its portfolio in oncology PARIS, FRANCE, 12 August 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the closing of the definitive merger agreement under which Ipsen has acquired Epizyme, Inc. (Epizyme). Pursuant to…
businesswire.com Ipsen Completes Acquisition of Epizyme Expanding Its Portfolio in Oncology PARIS--(BUSINESS WIRE)--Regulatory News: Disclaimer: Intended for international media and investor audiences only Ipsen (Euronext: IPN; ADR: IPSEY) today announced the closing of the definitive…
zacks.com Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y Epizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates.
zacks.com Epizyme (EPZM) Reports Q2 Loss, Tops Revenue Estimates Epizyme (EPZM) delivered earnings and revenue surprises of 41.67% and 172.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
businesswire.com Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering transformative therapies for cancer patients…
businesswire.com Ipsen Extends Expiration Date of Tender Offer for Epizyme, Inc. to 11 August 2022 PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen S.A. (Euronext: IPN; ADR: IPSEY) today announced that Hibernia Merger Sub, Inc. (Purchaser), its wholly owned indirect subsidiary, has extended the…
businesswire.com EPIZYME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Epizyme, Inc. - EPZM NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Epizyme, Inc.…
headlinesoftoday.com SHAREHOLDER ALERT: Weiss Law Reminds FSTX, ZEN, RDUS, and EPZM Shareholders About Its Ongoing Investigations NEW YORK, July 6, 2022 /PRNewswire/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any...
newsfilecorp.com SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Epizyme, Inc. Merger Wilmington, Delaware--(Newsfile Corp. - June 28, 2022) - Rigrodsky Law, P.A. is investigating Epizyme, Inc. ("Epizyme") (NASDAQ: EPZM) regarding possible breaches of fiduciary duties and other…
benzinga.com This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
prnewswire.com Shareholder Alert - The M&A Class Action Firm Announces an Investigation of Epizyme, Inc. - EPZM NEW YORK , June 27, 2022 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm…
prnewswire.com SHAREHOLDER ALERT: Weiss Law Investigates Epizyme, Inc. NEW YORK , June 27, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Epizyme, Inc. ("Epizyme" or the…
benzinga.com Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
fool.com Why Epizyme Stock Is Soaring Today A buyout ends Epizyme's 15-year tenure as an independent biopharma.
prnewswire.com Shareholder Alert: Ademi LLP investigates whether Epizyme, Inc. has obtained a Fair Price in its transaction with Ipsen MILWAUKEE , June 27, 2022 /PRNewswire/ -- Ademi LLP is investigating Epizyme (NASDAQ:EPZM) for possible breaches of fiduciary duty and other violations of law in its transaction with Ipsen. Click…
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022 Upgrades
businesswire.com EPZM Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Epizyme, Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Epizyme, Inc. (NASDAQ: EPZM) to Ipsen is fair to Epizyme shareholders. Halper Sadeh…
benzinga.com Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why Ipsen SA (OTC: IPSEY) has agreed to acquire Epizyme Inc (NASDAQ: EPZM) at $1.45 per share for approximately $247 million, plus one contingent value right (CVR) per share. The deal is expected to…
marketwatch.com Ipsen to acquire U.S.-based Epizyme for $247 million. By Joshua Kirby
businesswire.com Ipsen to Acquire Epizyme, Expanding Its Portfolio in Oncology PARIS & CAMBRIDGE, MASS.--(BUSINESS WIRE)--Regulatory News: Disclaimer: Intended for international media and investor audiences only Ipsen (Euronext: IPN; ADR: IPSEY) and Epizyme (Nasdaq: EPZM) today…
zacks.com Why Is Epizyme (EPZM) Up 51.7% Since Last Earnings Report? Epizyme (EPZM) reported earnings 30 days ago. What's next for the stock?
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 215 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 540 companies set new 52-week lows.
benzinga.com 99 Biggest Movers From Yesterday Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 807 companies reached new 52-week lows.
- benzinga.com Earnings Scheduled For May 10, 2022 Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 849 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 466 companies hit new 52-week lows.- benzinga.com The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution Here's a roundup of top developments in the biotech space over the last 24 hours:
- benzinga.com Earnings Scheduled For March 1, 2022 Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter.
- benzinga.com The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the…
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 615 stocks hit new 52-week lows.
- benzinga.com The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Here's a roundup of top developments in the biotech space over the last 24 hours:
benzinga.com Earnings Scheduled For November 9, 2021 Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.- benzinga.com The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday morning, 155 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday morning, 173 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday morning, 136 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday morning, 282 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday morning, 207 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday Before 10 a.m. ET Monday, 63 stocks made new 52-week lows.
- benzinga.com Earnings Scheduled For August 9, 2021 Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's morning session, 216 companies made new 52-week lows.
- benzinga.com 70 Biggest Movers From Friday Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.
- benzinga.com Mid-Afternoon Market Update: Dow Surges Over 200 Points; ChemoCentryx Shares Drop Toward the end of trading Friday, the Dow traded up 0.62% to 34,761.24 while the NASDAQ rose 0.95% to 13,762.12. The S&P also rose, gaining 0.74% to 4,232.81.
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com Mid-Day Market Update: Pro-Dex Rises After Q3 Results; Orphazyme Shares Slide Midway through trading Friday, the Dow traded up 0.45% to 34,705.48 while the NASDAQ rose 1.35% to 13,816.46. The S&P also rose, gaining 0.77% to 4,233.93.
- benzinga.com 56 Stocks Moving In Friday's Mid-Day Session Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321.